Geode Capital Management’s Decoy Therapeutics DCOY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-910
| Closed | -$7.08K | – | 4589 |
|
|
2025
Q4 | $7.08K | Buy |
+910
| New | +$23.6K | ﹤0.01% | 4445 |
|
|
2025
Q3 | – | Sell |
-86
| Closed | -$13.9K | – | 4553 |
|
|
2025
Q2 | $13.9K | Buy |
86
+22
| +34% | +$3.09K | ﹤0.01% | 4405 |
|
|
2025
Q1 | $8.67K | Buy |
+64
| New | +$18.6K | ﹤0.01% | 4438 |
|
|
2024
Q2 | – | Sell |
-17
| Closed | -$13.1K | – | 4620 |
|
|
2024
Q1 | $13.1K | Hold |
17
| – | – | ﹤0.01% | 4530 |
|
|
2023
Q4 | $15.9K | Hold |
17
| – | – | ﹤0.01% | 4547 |
|
|
2023
Q3 | $16.4K | Buy |
17
+6
| +55% | +$7.95K | ﹤0.01% | 4660 |
|
|
2023
Q2 | $24.6K | Hold |
11
| – | – | ﹤0.01% | 4632 |
|
|
2023
Q1 | $31.7K | Hold |
11
| – | – | ﹤0.01% | 4617 |
|
|
2022
Q4 | $25K | Hold |
11
| – | – | ﹤0.01% | 4734 |
|
|
2022
Q3 | $80K | Hold |
11
| – | – | ﹤0.01% | 4652 |
|
|
2022
Q2 | $86K | Hold |
11
| – | – | ﹤0.01% | 4642 |
|
|
2022
Q1 | $155K | Hold |
11
| – | – | ﹤0.01% | 4496 |
|
|
2021
Q4 | $193K | Buy |
11
+1
| +10% | +$26.5K | ﹤0.01% | 4491 |
|
|
2021
Q3 | $363K | Buy |
10
+2
| +25% | +$69K | ﹤0.01% | 4177 |
|
|
2021
Q2 | $293K | Buy |
8
+5
| +167% | +$222K | ﹤0.01% | 4172 |
|
|
2021
Q1 | $182K | Buy |
3
+2
| +200% | +$115K | ﹤0.01% | 4141 |
|
|
2020
Q4 | $16K | Hold |
1
| – | – | ﹤0.01% | 4261 |
|
|
2020
Q3 | $15K | Hold |
1
| – | – | ﹤0.01% | 4132 |
|
|
2020
Q2 | $24K | Hold |
1
| – | – | ﹤0.01% | 4058 |
|
|
2020
Q1 | $12K | Hold |
1
| – | – | ﹤0.01% | 4070 |
|
|
2019
Q4 | $69K | Buy |
+1
| New | +$160K | ﹤0.01% | 4039 |
|
|
2019
Q3 | – | Hold |
0
| – | -$97K | – | 4232 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 3969 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4089 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4096 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4081 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 3970 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 3589 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 3681 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 3667 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 3634 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3447 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3349 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3008 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3042 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3056 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3026 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 3024 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 2860 |
|
Other funds holding DCOY
Geode Capital Management's DCOY Position: Q1 2026 in Review
Geode Capital Management sold out of Decoy Therapeutics (DCOY) in Q1 2026, closing a stake of 910 shares — an estimated $7.08K sold.
Geode Capital Management first reported a position in DCOY in Q4 2019 and held it in 21 quarters. The position peaked at $363K in Q3 2021. 4 funds tracked by Wall St. Rank hold DCOY as of Q1 2026.
- Geode Capital Management reported no remaining Decoy Therapeutics position as of Q1 2026 after selling out during the quarter.
- Geode Capital Management sold 910 Decoy Therapeutics shares in Q1 2026, an estimated $7.08K.
- Geode Capital Management first reported a position in Decoy Therapeutics in Q4 2019 and held it in 21 quarters.
- Geode Capital Management's Decoy Therapeutics position peaked at $363K in Q3 2021.
- 4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.